Overview

Banlangen Granules Anti-seasonal Influenza Study

Status:
Unknown status

Trial end date:
2016-11-01

Target enrollment:

Participant gender:

Summary

This study aimed to evaluate the efficacy and safety of the nature herbal medicine Banlangen granules in patients infected with seasonal influenza A (H1N1,H3N2) and influenza B virus.

Phase:

Phase 4

Details

Lead Sponsor:

Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited

Collaborator:

Guangzhou Institute of Respiratory Disease

Treatments:

Oseltamivir